Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): A cohort study of newly diagnosed patients

British Journal of Haematology

Volumn 162, Issue 6, 2013, Pages 774-782

  Parikh, Sameer A ^a   Rabe, Kari G ^a   Call, Timothy G ^a   Zent, Clive S ^a   Habermann, Thomas M ^a   Ding, Wei ^a   Leis, Jose F ^b   Schwager, Susan M ^a   Hanson, Curtis A ^a   Macon, William R ^a   Kay, Neil E ^a   Slager, Susan L ^a   Shanafelt, Tait D ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Aggressive lymphoma; Purine analogues; Richter syndrome survival score; Stem cell transplantation; Transformation

Indexed keywords

ALKYLATING AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; PROTEIN KINASE ZAP 70; PURINE DERIVATIVE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; DISEASE COURSE; DRUG EFFICACY; FEMALE; GENE MUTATION; HUMAN; IGHV GENE; IGHV4 39 GENE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SURVIVAL RATE; TREATMENT RESPONSE;

AGGRESSIVE LYMPHOMA; PURINE ANALOGUES; RICHTER SYNDROME SURVIVAL SCORE; STEM CELL TRANSPLANTATION; TRANSFORMATION;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; YOUNG ADULT;

EID: 84883305814     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12458     Document Type: Article

References (29)

1. Armitage, J.O., Dick, F.R. & Corder, M.P. (1978) Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer, 41, 422-427.
2. Aydin, S., Rossi, D., Bergui, L., D'Arena, G., Ferrero, E., Bonello, L., Omede, P., Novero, D., Morabito, F., Carbone, A., Gaidano, G., Malavasi, F. & Deaglio, S. (2008) CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? Blood, 111, 5646-5653.
3. Catovsky, D., Richards, S., Matutes, E., Oscier, D., Dyer, M.J., Bezares, R.F., Pettitt, A.R., Hamblin, T., Milligan, D.W., Child, J.A., Hamilton, M.S., Dearden, C.E., Smith, A.G., Bosanquet, A.G., Davis, Z., Brito-Babapulle, V., Else, M., Wade, R. & Hillmen, P. (2007) Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet, 370, 230-239.
4. Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. & Rai, K.R. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990-4997.
5. Cwynarski, K., van Biezen, A., de Wreede, L., Stilgenbauer, S., Bunjes, D., Metzner, B., Koza, V., Mohty, M., Remes, K., Russell, N., Nagler, A., Scholten, M., de Witte, T., Sureda, A. & Dreger, P. (2012) Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): a retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology, 30, 2211-2217.
6. Eichhorst, B.F., Busch, R., Hopfinger, G., Pasold, R., Hensel, M., Steinbrecher, C., Siehl, S., Jager, U., Bergmann, M., Stilgenbauer, S., Schweighofer, C., Wendtner, C.M., Dohner, H., Brittinger, G., Emmerich, B. & Hallek, M. (2006) Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia. Blood, 107, 885-891.
7. Fan, L., Wang, L., Zhang, R., Fang, C., Zhu, D.X., Wang, Y.H., Zou, Z.J., Li, J.Y. & Xu, W. (2012) Richter transformation in 16 of 149 Chinese patients with chronic lymphocytic leukemia. Leukemia & Lymphoma, 53, 1749-1756.
8. Fischer, K., Bahlo, J., Fink, A.-M., Busch, R., Bottcher, S., Mayer, J., Dreger, P., Maurer, C., Engelke, A., Kneba, M., Dohner, H., Eichhorst, B.F., Wendtner, C.-M., Stilgenbauer, S. & Hallek, M. (2012) Extended Follow up of the CLL8 Protocol, a Randomized Phase-III Trial of the German CLL Study Group (GCLLSG) Comparing Fludarabine and Cyclophosphamide (FC) to FC Plus Rituximab (FCR) for Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): Results on Survival, Progression-Free Survival, Delayed Neutropenias and Secondary Malignancies Confirm Superiority of the FCR Regimen. ASH Annual Meeting Abstracts, 120, 435.
9. Flinn, I.W., Neuberg, D.S., Grever, M.R., Dewald, G.W., Bennett, J.M., Paietta, E.M., Hussein, M.A., Appelbaum, F.R., Larson, R.A., Moore, D.F. Jr & Tallman, M.S. (2007) Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 25, 793-798.
10. Foucar, K. & Rydell, R.E. (1980) Richter's syndrome in chronic lymphocytic leukemia. Cancer, 46, 118-134.
11. Hallek, M., Fischer, K., Fingerle-Rowson, G., Fink, A.M., Busch, R., Mayer, J., Hensel, M., Hopfinger, G., Hess, G., von Grunhagen, U., Bergmann, M., Catalano, J., Zinzani, P.L., Caligaris-Cappio, F., Seymour, J.F., Berrebi, A., Jager, U., Cazin, B., Trneny, M., Westermann, A., Wendtner, C.M., Eichhorst, B.F., Staib, P., Buhler, A., Winkler, D., Zenz, T., Bottcher, S., Ritgen, M., Mendila, M., Kneba, M., Dohner, H. & Stilgenbauer, S. (2010) Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet, 376, 1164-1174.
12. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 17, 3835-3849.
13. Hillmen, P., Skotnicki, A.B., Robak, T., Jaksic, B., Dmoszynska, A., Wu, J., Sirard, C. & Mayer, J. (2007) Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 25, 5616-5623.
14. Knauf, W.U., Lissichkov, T., Aldaoud, A., Liberati, A., Loscertales, J., Herbrecht, R., Juliusson, G., Postner, G., Gercheva, L., Goranov, S., Becker, M., Fricke, H.J., Huguet, F., Del Giudice, I., Klein, P., Tremmel, L., Merkle, K. & Montillo, M. (2009) Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27, 4378-4384.
15. Lortholary, P., Boiron, M., Ripault, P., Levy, J.P., Manus, A. & Bernard, J. (1964) [Chronic Lymphoid Leukemia Secondarily Associated with a Malignant Reticulopathy: Richter's Syndrome]. Nouvelle Revue Francaise D'hematologie, 4, 621-644.
16. Mauro, F.R., Foa, R., Giannarelli, D., Cordone, I., Crescenzi, S., Pescarmona, E., Sala, R., Cerretti, R. & Mandelli, F. (1999) Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood, 94, 448-454.
17. Richter, M.N. (1928) Generalized Reticular Cell Sarcoma of Lymph Nodes Associated with Lymphatic Leukemia. The American Journal of Pathology, 4, 287.
18. Robak, T., Blonski, J.Z., Gora-Tybor, J., Kasznicki, M., Konopka, L., Ceglarek, B., Komarnicki, M., Lewandowski, K., Hellmann, A., Moskwa, A., Dmoszynska, A., Sokolowska, B., Dwilewicz-Trojaczek, A., Tomaszewska, A., Sulek, K. & Calbecka, M. (2004) Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. European Journal of Cancer, 40, 383-389.
19. Robertson, L.E., Pugh, W., O'Brien, S., Kantarjian, H., Hirsch-Ginsberg, C., Cork, A., McLaughlin, P., Cabanillas, F. & Keating, M.J. (1993) Richter's syndrome: a report on 39 patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 11, 1985-1989.
20. Rossi, D., Cerri, M., Capello, D., Deambrogi, C., Rossi, F.M., Zucchetto, A., De Paoli, L., Cresta, S., Rasi, S., Spina, V., Franceschetti, S., Lunghi, M., Vendramin, C., Bomben, R., Ramponi, A., Monga, G., Conconi, A., Magnani, C., Gattei, V. & Gaidano, G. (2008) Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. British Journal of Haematology, 142, 202-215.
21. Rossi, D., Spina, V., Cerri, M., Rasi, S., Deambrogi, C., De Paoli, L., Laurenti, L., Maffei, R., Forconi, F., Bertoni, F., Zucca, E., Agostinelli, C., Cabras, A., Lucioni, M., Martini, M., Magni, M., Deaglio, S., Ladetto, M., Nomdedeu, J.F., Besson, C., Ramponi, A., Canzonieri, V., Paulli, M., Marasca, R., Larocca, L.M., Carbone, A., Pileri, S.A., Gattei, V. & Gaidano, G. (2009a) Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 15, 4415-4422.
22. Rossi, D., Lobetti Bodoni, C., Genuardi, E., Monitillo, L., Drandi, D., Cerri, M., Deambrogi, C., Ricca, I., Rocci, A., Ferrero, S., Bernocco, E., Capello, D., De Paoli, L., Bergui, L., Boi, M., Omede, P., Massaia, M., Tarella, C., Passera, R., Boccadoro, M., Gaidano, G. & Ladetto, M. (2009b) Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 23, 1062-1072.
23. Rossi, D., Spina, V., Deambrogi, C., Rasi, S., Laurenti, L., Stamatopoulos, K., Arcaini, L., Lucioni, M., Rocque, G.B., Xu-Monette, Z.Y., Visco, C., Chang, J., Chigrinova, E., Forconi, F., Marasca, R., Besson, C., Papadaki, T., Paulli, M., Larocca, L.M., Pileri, S.A., Gattei, V., Bertoni, F., Foa, R., Young, K.H. & Gaidano, G. (2011) The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood, 117, 3391-3401.
24. Rossi, D., Rasi, S., Spina, V., Fangazio, M., Monti, S., Greco, M., Ciardullo, C., Fama, R., Cresta, S., Bruscaggin, A., Laurenti, L., Martini, M., Musto, P., Forconi, F., Marasca, R., Larocca, L.M., Foa, R. & Gaidano, G. (2012) Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. British Journal of Haematology, 158, 426-429.
25. Solh, M., Rai, K.R., Peterson, B.L., Kolitz, J.E., Appelbaum, F.R., Tallman, M.S., Belch, A., Larson, R.A. & Morrison, V.A. (2013) The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011). Leukemia & Lymphoma, 54, 252-254.
26. Tam, C.S., O'Brien, S., Wierda, W., Kantarjian, H., Wen, S., Do, K.A., Thomas, D.A., Cortes, J., Lerner, S. & Keating, M.J. (2008) Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. Blood, 112, 975-980.
27. Tsimberidou, A.M., O'Brien, S., Khouri, I., Giles, F.J., Kantarjian, H.M., Champlin, R., Wen, S., Do, K.A., Smith, S.C., Lerner, S., Freireich, E.J. & Keating, M.J. (2006) Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24, 2343-2351.
28. Wierda, W.G., Kipps, T.J., Durig, J., Griskevicius, L., Stilgenbauer, S., Mayer, J., Smolej, L., Hess, G., Griniute, R., Hernandez-Ilizaliturri, F.J., Padmanabhan, S., Gorczyca, M., Chang, C.N., Chan, G., Gupta, I., Nielsen, T.G. & Russell, C.A. (2011) Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia. Blood, 117, 6450-6458.
29. Woyach, J.A., Ruppert, A.S., Heerema, N.A., Peterson, B.L., Gribben, J.G., Morrison, V.A., Rai, K.R., Larson, R.A. & Byrd, J.C. (2011) Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712. Journal of Clinical Oncology, 29, 1349-1355.